Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Zelira Therapeutics Limited?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Zelira Therapeutics Limited market cap is $3.42M.
What is the 52-week high for Zelira Therapeutics Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zelira Therapeutics Limited 52 week high is $0.4165 as of October 06, 2026.
What is the 52-week low for Zelira Therapeutics Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zelira Therapeutics Limited 52 week low is $0.20 as of October 06, 2026.
What is Zelira Therapeutics Limited stock price today?
Zelira Therapeutics Limited stock price today is $0.26.
What was Zelira Therapeutics Limited stock price yesterday?
Zelira Therapeutics Limited stock price yesterday was $0.26.
What is the 50-day moving average of Zelira Therapeutics Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Zelira Therapeutics Limited 50-day moving average is $0.268.